News & Events
Marlins Triple Play 5K
October 17, 2024
Please join us for the 3rd Annual Marlins Triple Play 5K, presented by UHealth, on November 3rd, 2024! People of all ages are invited to round the bases on the …
Read more2024 CReATe Consortium Annual Meeting
August 15, 2024
Sunday, August 18th, 2024 through Tuesday, August 20th, 2024, Dr. Michael Benatar at the University of Miami will be hosting the CReATe Consortium Annual Meeting in Miami Beach, FL. This …
Read moreAdvancing Hope: AFTD Attends C9orf72 FTD/ALS Prevention Trial Workshop
August 6, 2024
Dr. Adam Boxer at the University of California San Francisco and Dr. Michael Benatar at the University of Miami hosted a one-day C9orf72 FTD/ALS Prevention Trial Workshop in June 2024 …
Read moreWalk to Defeat ALS – ALS Association
April 3, 2024
Help us unlock ALS on the Walk to Defeat ALS Miami hosted by the ALS Association! Saturday, May 18, 2024 at Tropical Park (7900 SW 40th St Miami, FL) Check-in …
Read moreJNNP Podcast: A Roadmap to ALS Prevention – Strategies and Priorities with Dr. Michael Benatar
March 1, 2024
Listen Now
Read moreThe Genetics Podcast: Breakthroughs and Insights in ALS Research with Dr. Michael Benatar
March 1, 2024
Listen Now
Read moreInside U Miami Medicine Podcast: Unraveling the Mysteries of ALS with Dr. Michael Benatar
March 1, 2024
Listen Now
Read more2024 Annual ALS Patient Symposium
January 31, 2024
The ALS Patient Symposium is an annual event, offering patients, family members and health care providers an opportunity to learn about what’s new in ALS patient care and research. This …
Read moreDr. Michael Benatar Honored for Innovative ALS Discoveries
January 11, 2024
University of Miami Miller School of Medicine neurologist Michael Benatar, M.D., Ph.D., was one of seven researchers who received the Sean M. Healey International Prize for Innovation in ALS at the 34th International Symposium on ALS/MND …
Read moreMarlins Triple Play 5K
November 29, 2023
Please join us for the 2nd Annual Marlins Triple Play 5K, presented by UHealth, on December 16, 2023! People of all ages are invited to round the bases on the …
Read moreGuiding Clinical Care for People at Risk for ALS and FTD
October 13, 2023
An international workshop co-led by University of Miami Miller School of Medicine neurologist Michael Benatar, M.D., Ph.D., laid the foundation for developing guidance for the clinical care of people at elevated genetic …
Read moreInternational Workshop Focuses on Defining Prodromal Phases of ALS, FTD
May 2, 2023
Michael Benatar, M.D., Ph.D., at the University of Miami organized and hosted the Second International Pre-Symptomatic ALS Workshop on February 27, 2023, which focused on defining the prodromal stages of …
Read moreNew Grants Support Six Projects with ‘Ambitious Goal’ of Preventing ALS
February 16, 2023
Read the full update at the link below. View update
Read moreDealing ALS a New Hand
December 7, 2022
Research reveals clues that may enable treatment even before symptoms show. Read the full article at the link below. View Article
Read moreMiller School Studies Pave the Way for the First Pre-Symptomatic ALS Trial for Individuals with SOD1 Genetic Mutation
May 7, 2021
For more than a decade, investigators at the University of Miami Miller School of Medicine have been studying the earliest signs of amyotrophic lateral sclerosis (ALS). Now, armed with biomarkers …
Read moreUM Researchers’ Validation of ALS Biomarker Could Accelerate Development of New Therapies
May 6, 2020
Researchers at the University of Miami Miller School of Medicine have validated a biomarker for amyotrophic lateral sclerosis (ALS) – a finding that could lead to faster and more efficient …
Read moreALS Center investigators host first international Pre-Symptomatic ALS Workshop
February 9, 2020
The first Pre-Symptomatic ALS Workshop, organized and hosted by Dr. Michael Benatar (University of Miami), took place in Miami on January 27th, 2020. This Workshop brought together ~40 specialists in …
Read moreCReATe Consortium Aims for ALS Breakthroughs with NIH Renewal Grant
October 4, 2019
An international research consortium led by investigators at the University of Miami Miller School of Medicine has made significant progress in understanding amyotrophic lateral sclerosis (ALS) and related diseases since …
Read morePhase III Trial Evaluating Arimoclomol for ALS Patients Reaches Full Enrollment
July 18, 2019
An international phase III clinical trial evaluating the drug Arimoclomol for the treatment of amyotrophic lateral sclerosis (ALS) has reached full enrollment, as reported by a University of Miami Miller …
Read more